COVID-19 vaccines for children: An expert explains
The Pfizer/BioNTech vaccine is set to be approved for children aged 5-11 in the United States. Image: REUTERS/Dado Ruvic/File Photo/File Photo
Kate McAlpine
Senior news and feature writer, Michigan College of Health
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
COVID-19
India’s leading COVID-19 last-mile responders
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
Subscribe
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
